Orient Pharma Balance Sheet Health
Financial Health criteria checks 3/6
Orient Pharma has a total shareholder equity of NT$1.7B and total debt of NT$487.3M, which brings its debt-to-equity ratio to 29.2%. Its total assets and total liabilities are NT$2.6B and NT$892.2M respectively. Orient Pharma's EBIT is NT$24.3M making its interest coverage ratio 2. It has cash and short-term investments of NT$113.1M.
Key information
29.2%
Debt to equity ratio
NT$487.27m
Debt
| Interest coverage ratio | 2x |
| Cash | NT$113.12m |
| Equity | NT$1.67b |
| Total liabilities | NT$892.18m |
| Total assets | NT$2.56b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 4166's short term assets (NT$622.3M) exceed its short term liabilities (NT$563.4M).
Long Term Liabilities: 4166's short term assets (NT$622.3M) exceed its long term liabilities (NT$328.8M).
Debt to Equity History and Analysis
Debt Level: 4166's net debt to equity ratio (22.4%) is considered satisfactory.
Reducing Debt: 4166's debt to equity ratio has increased from 12.4% to 29.2% over the past 5 years.
Debt Coverage: 4166's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 4166's interest payments on its debt are not well covered by EBIT (2x coverage).